Fortive Corp FTV
We take great care to ensure that the data presented and summarized in this overview for Fortive Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding FTV
View all-
Vanguard Group Inc Valley Forge, PA39.1MShares$2.92 Billion0.06% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD32.2MShares$2.4 Billion1.51% of portfolio
-
Black Rock Inc. New York, NY30.5MShares$2.27 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA15MShares$1.12 Billion0.2% of portfolio
-
State Street Corp Boston, MA13.9MShares$1.03 Billion0.05% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M11.2MShares$834 Million3.5% of portfolio
-
Royal Bank Of Canada Toronto, A611.2MShares$833 Million0.19% of portfolio
-
Viking Global Investors LP10MShares$749 Million2.96% of portfolio
-
Brown Advisory Inc8.8MShares$656 Million0.87% of portfolio
-
Geode Capital Management, LLC Boston, MA8.15MShares$607 Million0.05% of portfolio
Latest Institutional Activity in FTV
Top Purchases
Top Sells
About FTV
Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Insider Transactions at FTV
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 13
2024
|
Charles E Mc Laughlin SVP - Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,864
-8.55%
|
$507,936
$74.03 P/Share
|
Sep 13
2024
|
Jonathan L Schwarz SVP - Corporate Development |
SELL
Open market or private sale
|
Direct |
14,223
-17.26%
|
$1,038,279
$73.8 P/Share
|
Sep 13
2024
|
Jonathan L Schwarz SVP - Corporate Development |
BUY
Exercise of conversion of derivative security
|
Direct |
14,223
+14.72%
|
$497,805
$35.31 P/Share
|
Aug 23
2024
|
Olumide Soroye President & CEO of IOS |
SELL
Payment of exercise price or tax liability
|
Direct |
9,579
-8.03%
|
$699,267
$73.39 P/Share
|
Aug 15
2024
|
Christopher M. Mulhall VP - Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
129
-1.73%
|
$8,901
$69.79 P/Share
|
Aug 13
2024
|
James A Lico President and CEO |
SELL
Bona fide gift
|
Indirect |
44,583
-100.0%
|
-
|
Jul 15
2024
|
Charles E Mc Laughlin SVP - Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,573
-10.66%
|
$727,548
$76.23 P/Share
|
Jul 15
2024
|
Charles E Mc Laughlin SVP - Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,816
+14.16%
|
$459,296
$31.75 P/Share
|
Jun 03
2024
|
Jeannine P Sargent Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,970
+10.45%
|
-
|
Jun 03
2024
|
Kate Mitchell Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,955
+5.13%
|
$112,290
$38.07 P/Share
|
Jun 03
2024
|
Sharmistha Dubey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,615
+10.11%
|
$137,370
$38.07 P/Share
|
Jun 03
2024
|
Eric Branderiz Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,680
+17.1%
|
$139,840
$38.07 P/Share
|
Jun 03
2024
|
Daniel L Comas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,970
+4.17%
|
-
|
Jun 03
2024
|
Rejji P Hayes Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,680
+9.6%
|
$139,840
$38.07 P/Share
|
Jun 03
2024
|
Wright Lassiter Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,485
+13.14%
|
$132,430
$38.07 P/Share
|
Jun 03
2024
|
Alan G Spoon Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,745
+2.49%
|
$218,310
$38.07 P/Share
|
May 15
2024
|
Tamara S. Newcombe President & CEO of AHS and PT |
SELL
Payment of exercise price or tax liability
|
Direct |
597
-0.85%
|
$45,969
$77.79 P/Share
|
May 15
2024
|
James A Lico President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,593
-3.71%
|
$1,431,661
$77.79 P/Share
|
May 15
2024
|
James A Lico President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,480
+5.56%
|
$884,400
$30.42 P/Share
|
Mar 04
2024
|
Charles E Mc Laughlin SVP - Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,110
+15.83%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 217K shares |
---|---|
Exercise of conversion of derivative security | 294K shares |
Payment of exercise price or tax liability | 112K shares |
---|---|
Bona fide gift | 44.6K shares |
Open market or private sale | 303K shares |